Everolimus

Red

Brand Name(s):Votubia

Indication:Renal angiomyolipoma associated with tuberous sclerosis complex

Rationale:1,2,3

Considered:Nov-12

Review Date:May-23

Comments:
NICE TA 348

Everolimus for preventing organ rejection in liver transplantation

Everolimus (Certican) is not recommended for preventing organ rejection in people having a liver transplant. Full details available at:http://www.nice.org.uk/guidance/ta348/resources/guidance-everolimus-for-preventing-organ-rejection-in-liver-transplantation-pdf
July 2015